Max

Max Ma currently serves as the Director of Translational Oncology - Clinical Development at ALX Oncology, a position held since September 2024. Prior experience includes the role of Executive Director of Medical Information in Medical Affairs at Coherus BioSciences from November 2020 to September 2024, where responsibilities included managing the Medical Information Call Center and vendor management. At Foundation Medicine, Max held the position of Director of Medical Communications, overseeing a team and executing training initiatives from June 2019 to November 2020. Earlier career highlights at Roche Sequencing Solutions, Inc. include serving as Director of Medical Affairs and launching three products as Project Leader, alongside managing a team of scientists in late-stage research. Max holds a PhD in Biochemistry from the University of Rochester School of Medicine and Dentistry and a BS in Biotechnology and Biopharmaceutical Sciences from Nanjing University and China Pharmaceutical University.